Literature DB >> 2874275

Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study.

M J Campion, D J McCance, J Cuzick, A Singer.   

Abstract

A prospective study of 100 women with cytological and colposcopic evidence of mild cervical atypia consistent with cervical intraepithelial neoplasia (CIN) grade I was started in October, 1983. 26% of early preinvasive cervical lesions progressed to histologically proven CIN III. Spontaneous regression of mild cervical atypia occurred in only 11 cases, and in 4 of these CIN recurred. The overall prevalence of human papillomavirus type 16 (HPV 16) in the study group, detected by filter DNA-DNA hybridisation of a cervical cytological specimen, was 39%. However, 22 of the 26 (85%) cases of progressive disease were positive for HPV 16. Detection of HPV 16 may be a non-invasive way of identifying women at high risk of rapid progression of mild cervical atypia to CIN III.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874275     DOI: 10.1016/s0140-6736(86)92067-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  68 in total

Review 1.  How can we develop a cost-effective quality cervical screening programme?

Authors:  Sue Wilson; Helen Lester
Journal:  Br J Gen Pract       Date:  2002-06       Impact factor: 5.386

Review 2.  Abnormal cervical smear test results: old dilemmas and new directions.

Authors:  C Wilkinson
Journal:  Br J Gen Pract       Date:  1992-08       Impact factor: 5.386

3.  Review of an Irish cervical smear service.

Authors:  J Dolan; E Ryan; M Thornhill; B Curran; M Leader
Journal:  Ir J Med Sci       Date:  1990-08       Impact factor: 1.568

4.  Routine papillomavirus antigen staining of cervical punch biopsy specimens.

Authors:  D Jenkins; S K Tay; P H Maddox
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

5.  Characterization of in vivo expression of the human papillomavirus type 16 E4 protein in cervical biopsy tissues.

Authors:  J M Palefsky; B Winkler; J P Rabanus; C Clark; S Chan; V Nizet; G K Schoolnik
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 6.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

7.  Complacency in diagnosis of cervical cancer.

Authors:  M J Campion; A Singer; H S Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23

8.  Quantitative DNA analysis of low grade cervical intraepithelial neoplasia and human papillomavirus infection by static and flow cytometry.

Authors:  K C Watts; O A Husain; M J Campion; F Lorriman; E B Butler; D McCance; D Jenkins; A Singer
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

Review 9.  Use of the polymerase chain reaction to study the relationship between human papillomavirus infections and cervical cancer.

Authors:  W J Melchers; H C Claas; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

10.  Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

Authors:  Julia C Gage; William C Hunt; Mark Schiffman; Hormuzd A Katki; Li C Cheung; Jack Cuzick; Orrin Myers; Philip E Castle; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.